Analyst firms · J.P. Morgan · VIR
J.P. Morgan VIR price target and rating history
Vir Biotechnology Inc. (VIR) · Health Care
J.P. Morgan rates Vir Biotechnology Inc. (VIR) Neutral with a $9 price target, as of its latest action on Jan 29, 2024. It has published 3 rating actions on VIR since October 2021, including 2 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $9
- Median target, all firms
- Too few
- Actions on VIR
- 3
J.P. Morgan price target on VIR
Every J.P. Morgan rating on VIR
- Jan 29, 2024
- Mar 6, 2023
- Oct 25, 2021
Questions about J.P. Morgan and VIR
- What is J.P. Morgan's price target for VIR?
- J.P. Morgan's latest stated price target for Vir Biotechnology Inc. (VIR) is $9, from its action on Jan 29, 2024.
- What is J.P. Morgan's rating on VIR?
- J.P. Morgan rates VIR Neutral, a neutral rating, as of Jan 29, 2024.
- When did J.P. Morgan last change its view on VIR?
- On Jan 29, 2024, J.P. Morgan downgrades to Neutral from Overweight, price target $23 to $9.
More VIR rating histories
All J.P. Morgan ratingsVIR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.